Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Maiden Drill Program Commences at Oasis Uranium Project July 28, 2025 Next Post GTI Energy July 28, 2025 Related Posts Tech Weekly: CES Announcements Reignite Memory Shortage Concerns January 11, 2026 Is 2026 The Year The Cannabis Industry Matures? January 10, 2026 SAGA Metals Highlights Radar Titanium Opportunity as North America Confronts Defense Driven Titanium Supply Chain Risks January 10, 2026
SAGA Metals Highlights Radar Titanium Opportunity as North America Confronts Defense Driven Titanium Supply Chain Risks January 10, 2026